Gensight Biologics SA
PAR:SIGHT

Watchlist Manager

Gensight Biologics SA

PAR:SIGHT

Watchlist

Discount Rate

Price: 0.395 EUR 5.05% Market Closed

Market Cap: 40.9m EUR

Have any thoughts about
Gensight Biologics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 0.395 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SIGHT Alert

Gensight Biologics SA

0.395

+0.019 (+5.05%)

52 Week Range	0.29 0.704
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gensight Biologics SA

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gensight Biologics SA.

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gensight Biologics SA.

Provide P/S
for Gensight Biologics SA.

Provide P/E
for Gensight Biologics SA.

Provide P/OCF
for Gensight Biologics SA.

Provide P/FCFE
for Gensight Biologics SA.

Provide P/B
for Gensight Biologics SA.

Provide EV/S
for Gensight Biologics SA.

Provide EV/GP
for Gensight Biologics SA.

Provide EV/EBITDA
for Gensight Biologics SA.

Provide EV/EBIT
for Gensight Biologics SA.

Provide EV/OCF
for Gensight Biologics SA.

Provide EV/FCFF
for Gensight Biologics SA.

Provide EV/IC
for Gensight Biologics SA.

Show me price targets
for Gensight Biologics SA made by professional analysts.

What are the Revenue projections
for Gensight Biologics SA?

How accurate were the past Revenue estimates
for Gensight Biologics SA?

What are the Net Income projections
for Gensight Biologics SA?

How accurate were the past Net Income estimates
for Gensight Biologics SA?

What are the EPS projections
for Gensight Biologics SA?

How accurate were the past EPS estimates
for Gensight Biologics SA?

What are the EBIT projections
for Gensight Biologics SA?

How accurate were the past EBIT estimates
for Gensight Biologics SA?

Compare the revenue forecasts
for Gensight Biologics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gensight Biologics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gensight Biologics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gensight Biologics SA compared to its peers.

Compare the P/E ratios
of Gensight Biologics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gensight Biologics SA with its peers.

Analyze the financial leverage
of Gensight Biologics SA compared to its main competitors.

Show all profitability ratios
for Gensight Biologics SA.

Provide ROE
for Gensight Biologics SA.

Provide ROA
for Gensight Biologics SA.

Provide ROIC
for Gensight Biologics SA.

Provide ROCE
for Gensight Biologics SA.

Provide Gross Margin
for Gensight Biologics SA.

Provide Operating Margin
for Gensight Biologics SA.

Provide Net Margin
for Gensight Biologics SA.

Provide FCF Margin
for Gensight Biologics SA.

Show all solvency ratios
for Gensight Biologics SA.

Provide D/E Ratio
for Gensight Biologics SA.

Provide D/A Ratio
for Gensight Biologics SA.

Provide Interest Coverage Ratio
for Gensight Biologics SA.

Provide Altman Z-Score Ratio
for Gensight Biologics SA.

Provide Quick Ratio
for Gensight Biologics SA.

Provide Current Ratio
for Gensight Biologics SA.

Provide Cash Ratio
for Gensight Biologics SA.

What is the historical Revenue growth
over the last 5 years for Gensight Biologics SA?

What is the historical Net Income growth
over the last 5 years for Gensight Biologics SA?

What is the current Free Cash Flow
of Gensight Biologics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gensight Biologics SA.

Section:

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Wall Street analysts forecast SIGHT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.388 EUR with a low forecast of 0.364 EUR and a high forecast of 0.42 EUR.

SIGHT Lowest Forecast

Wall Street Target

0.364 EUR

8% Downside

SIGHT Average Forecast

Wall Street Target

0.388 EUR

2% Downside

SIGHT Highest Forecast

Wall Street Target

0.42 EUR

6% Upside

Lowest

Price Target

0.364 EUR

8% Downside

Average

Price Target

0.388 EUR

2% Downside

Highest

Price Target

0.42 EUR

6% Upside

Gensight Biologics SA Competitors:
Price Targets

FOLD

Amicus Therapeutics Inc

60% Upside

HALO

Halozyme Therapeutics Inc

3% Upside

ALEC

Alector Inc

128% Upside

IMTX

Immatics NV

59% Upside

FOLD

Amicus Therapeutics Inc

60% Upside

HALO

Halozyme Therapeutics Inc

3% Upside

ALEC

Alector Inc

128% Upside

IMTX

Immatics NV

59% Upside

301080

Acrobiosystems Co Ltd

79% Upside

VTVT

vTv Therapeutics Inc

87% Downside

688192

Dizal Jiangsu Pharmaceutical Co Ltd

65% Upside

VCEL

Vericel Corp

20% Upside

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

The compound annual growth rate of Gensight Biologics SA's revenue for the next 3 years is 70%.

N/A

Past Growth

70%

Estimated Growth

Estimates Accuracy

-54%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-67%

Average Miss

What are analyst estimates?

What is SIGHT's stock price target?

Price Target
0.388 EUR

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.388 EUR with a low forecast of 0.364 EUR and a high forecast of 0.42 EUR.

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
70%

The compound annual growth rate of Gensight Biologics SA's revenue for the next 3 years is 70%.

Gensight Biologics SA
PAR:SIGHT

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

See Also

What is SIGHT's stock price target?

Price Target
0.388 EUR

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
70%

Company

Help

Tools

Stocks

Gensight Biologics SA PAR:SIGHT

Wall Street Price Targets

SIGHT Price Targets Summary Gensight Biologics SA

Revenue Forecast

Revenue Estimate Gensight Biologics SA

Operating Income Forecast

Operating Income Estimate Gensight Biologics SA

Net Income Forecast

Net Income Estimate Gensight Biologics SA

See Also

What is SIGHT's stock price target? Price Target 0.388 EUR

What is Gensight Biologics SA's Revenue forecast? Projected CAGR 70%

Company

Help

Tools

Stocks

Gensight Biologics SA
PAR:SIGHT

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

What is SIGHT's stock price target?

Price Target
0.388 EUR

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
70%